IP Library Granted Patent US 9,566,372
Granted Patent B2
US 9,566,372 · App. 14/430,545 · Granted Feb 14, 2017

Sustained nitric oxide release coating using diazeniumdiolate-doped polymer matrix with ester capped poly(lactic-co-glycolic acid) additive

Inventors: Hitesh Handa (Ann Arbor, MI); Mark E. Meyerhoff (Ann Arbor, MI); Robert H. Bartlett (Ann Arbor, MI); Elizabeth J. Brisbois (Ann Arbor, MI); Lahdan Refahiyat (Ann Arbor, MI)
Assignee: The Regents of the University of Michigan
A61L31/16A61L29/049A61L29/141A61L29/16A61L31/041A61L31/141C08G18/61C08L27/06A61L2300/114A61L2300/802
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,566,372
App. No.
14/430,545
Granted
Feb 14, 2017
Kind
B2
Abstract

A polymeric composition includes a polymer matrix having a lipophilic discrete nitric oxide adduct and/or a polymeric nitric oxide adduct associated therewith, by covalent attachment to the polymer matrix and/or by dispersion within the polymer matrix, with the discrete nitric oxide adduct and/or the polymeric nitric oxide adduct being capable of releasing nitric oxide (NO). The polymeric composition further includes an ester capped poly(lactide-co-glycolide) (PLGA) additive to at least one of increase, prolong, and control NO release rates from the lipophilic discrete nitric oxide adduct and/or the polymeric nitric oxide adduct.

Claims (33)

1. A polymeric composition, comprising:

a polymer matrix having at least one of a lipophilic discrete nitric oxide adduct or a polymeric nitric oxide adduct associated therewith, by: covalent attachment to the polymeric matrix; dispersion within the polymeric matrix; or both, with the at least one of the discrete nitric oxide adduct or the polymeric nitric oxide adduct capable of releasing nitrous oxide (NO); and

an ester capped poly(lactide-co-glycolide) (PLGA) additive to at least one of increase, prolong, and control NO release rates from the at least one of the lipophilic discrete nitric oxide adduct or the polymeric nitric oxide adduct, the ester capped PLGA additive having a 65:35 ratio of lactic acid monomer to glycolic acid monomer.

2. The polymeric composition as defined in claim 1 wherein the polymer matrix comprises a hydrophobic polymer or a polymer with both hydrophobic and hydrophilic domains.

3. The polymeric composition as defined in claim 1 wherein the polymer matrix comprises at least one of poly(vinyl chloride), silicone rubbers, polyurethanes, polymethacrylates, polyacrylates, polycaprolactone, copolymers thereof, and mixtures thereof.

4. The polymeric composition as defined in claim 1 wherein the polymer matrix further comprises a plasticizer.

5. The polymeric composition as defined in claim 4 wherein the plasticizer comprises at least one of dioctyl sebacate, isopropyl palmitate, isopropyl isosterate, diisooctyl phthalate, o-nitrophenyloctyl ether, and mixtures thereof.

6. The polymeric composition as defined in claim 1 wherein the polymer matrix further comprises chromoionophores.

7. The polymeric composition as defined in claim 1 wherein the polymer matrix comprises poly(vinyl chloride).

8. The polymeric composition as defined in claim 1 wherein the polymer matrix comprises a polyurethane elastomer with poly(dimethylsiloxane) (PDMS) soft segments.

9. The polymeric composition as defined in claim 1 wherein:

the polymer matrix is poly(vinyl chloride) (PVC) or a polyurethane elastomer with poly(dimethylsiloxane) (PDMS) soft segments; and

the composition includes the lipophilic discrete nitric oxide (NO) adduct, the NO adduct being DBHD/N 2 O 2 (diazeniumdiolated dibutylhexane diamine).

10. The polymeric composition as defined in claim 9 wherein:

the polymer matrix includes 65 wt % of: the PVC and dioctyl sebacate (DOS) in a 2:1 ratio; or the polyurethane elastomer with poly(dimethylsiloxane) (PDMS) soft segments;

the composition includes 25 wt % DBHD/N 2 O 2 ; and

the composition includes 10 wt % of the 6535DLG7E PLGA.

11. A polymeric device, comprising:

a base polymer layer;

a top polymer layer disposed on the base polymer layer; and

at least one active layer between the base polymer layer and the top polymer layer, and the at least one active intermediate layer including the polymeric composition as defined in claim 1 .

12. A polymeric device, comprising:

a base polymer layer;

a top polymer layer disposed on the base polymer layer; and

at least one active layer between the base polymer layer and the top polymer layer, and the at least one active intermediate layer including the polymeric composition as defined in claim 9 .

13. The polymeric device as defined in claim 12 wherein:

the base polymer layer is PVC or the polyurethane elastomer with poly(dimethylsiloxane) (PDMS) soft segments; and

the top polymer layer is: PVC and dioctyl sebacate (DOS) in a 1:2 ratio; or the polyurethane elastomer with poly(dimethylsiloxane) (PDMS) soft segments.

14. The polymeric device as defined in claim 13 wherein the polymeric device is extracorporeal circuit (ECC) tubing or an intravascular catheter.

15. A method for making an NO-releasing polymeric composition, comprising the steps of:

providing a polymer matrix;

dispersing at least one of a lipophilic discrete nitric oxide adduct and a polymeric nitric oxide adduct within the polymeric matrix, the at least one of the discrete nitric oxide adduct or the polymeric nitric oxide adduct capable of releasing nitrous oxide (NO); and

selecting an ester capped poly(lactide-co-glycolide) (PLGA) additive to at least one of increase, prolong, and control NO release rates from the at least one of the lipophilic discrete nitric oxide adduct or the polymeric nitric oxide adduct, the ester capped PLGA additive having a 65:35 ratio of lactic acid monomer to glycolic acid monomer and having a hydrolysis rate that substantially matches the rate of production of amine sites formed after loss of NO from the at least one of the discrete nitric oxide adduct or the polymeric nitric oxide adduct.

Assignments (2)
CONFIRMATORY LICENSE Recorded Feb 21, 2017
From: UNIVERSITY OF MICHIGAN
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 041760/0052 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 20, 2015
From: HANDA, HITESH; MEYERHOFF, MARK E.; BARTLETT, ROBERT H.; BRISBOIS, ELIZABETH J.; REFAHIYAT, LAHDAN
To: THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Reel/Frame 035676/0851 →
Continuity (2)
Provisional Application 61707192 · Sep 28, 2012
Related Publication 20150238662A1 · Aug 27, 2015